| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |